• Home Interface Controller

    Sunstein has prosecuted a portfolio of patents devoted to the emerging industry of interactive television. Our client ICTV has developed technology that enables cable television subscribers to receive video programming that allows them to interact with their television to play games, videos and music on demand; browse news, sports and weather; and view targeted interactive advertising.

  • Molecular Diagnostic System

    We obtained the patent for Source Precision Medicine’s molecular diagnostic system that measures cellular gene expression with significant precision to assess and track an individual’s current health, disease status and response to drug therapy, potentially a foundation for the future practice of medicine.

  • Acoustic Analysis of Bone

    Patents prosecuted by Sunstein protect technologies, including transient signal processing techniques developed by the Metra Biosystems division of Quidel Corp., that are used in compact ultrasonic devices to measure bone density as an aid in detecting osteoporosis.

  • Magnetization Technology

    Sunstein successfully negotiated a multi-million dollar settlement on behalf of Comair Rotron, following a jury verdict that our client’s patent was infringed. The patent was directed to important magnetization technology for brushless DC electric motors.

Patents. Juries. Success.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

Abbott Laboratories v Syntron Bioresearch, Inc.

In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories.

Our successful advocacy extends to patent reexaminations and interferences.

Winning at Post Grant Proceedings

Apple Inc., Google Inc., Motorola Mobility LLC v. Arendi S.A.R.L.

We won a rare Federal Circuit Court of Appeals reversal of an IPR decision of the Patent Trial and Appeal Board, which had invalidated our client’s patent claims. The Federal Circuit accepted our argument that the Board had improperly relied on a “common sense” observation to invalidate Arendi’s patent.

Click here to learn more about Sunstein litigators.

Spotlight on Patents

A recent patent we obtained for our client Nexsan, of Santa Clara, CA,  U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of  individual users.  Data is shared on a peer-to-peer basis.  A central  server governs access based on user privileges without storing any of  the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.

In the News

  • Lisa Tittemore, SUNSTEIN Litigation Group Co-Chair, was a member of the committee that drafted extensive revisions to Local Rule 16.6, adopted by the U.S. District Court for D.MA effective June 1, 2018.  It is anticipated that the new rule will make the court a more appealing venue for patent litigation.

  • SUNSTEIN’s Federal Circuit Win in Exergen: Diagnostic Patents Survive Eligibility Challenge

    This is the first Federal Circuit decision upholding the patentability of a diagnostic patent since the Supreme Court struck down a diagnostic invention on patent eligibility grounds in Mayo v. Prometheus in 2012. More. . .  Law360 Article

  • SUNSTEIN has been named a Tier 1 firm in Boston for Litigation – Intellectual Property by U.S. News – Best Lawyers® “Best Law Firms” in 2018.

  • SUNSTEIN has been named a Recommended Firm by Chambers® in 2018.

     

  • Congratulations to our client Draper Laboratory for multiple awards for patents at the BPLA’s “Invented Here!” program. We are proud that Sunstein attorney George Jakobsche prosecuted the patents for Draper. More. . .

  • Sunstein successfully represented long-time client ’47 before USPTO’s TTAB preventing adversary’s registration of a 47 in a circle.  Read more here.

  • Congratulations to our client, the Broad Institute, on its Patent Trial and Appeal Board victory involving its patents for CRISPR gene-editing technology! We are pleased to have played a role in this victory. More. . .

  • Robert Asher wins Federal Circuit decision that issued a rare reversal of a PTAB patent invalidity decision and limited the discretion of the PTAB. More. . .

  • Bruce SunsteinKerry TimbersLisa TittemoreLawrence Green named to Best Lawyers in America©, 2018 list. More. . .

  • Lisa Tittemore, Kathy Williams, Ph.D.Dorothy Wu Chiang, Amy DeCloux, Ph.D., and Sharona Sternberg were named to the list of “Top Women Attorneys in Massachusetts” in Boston magazine.

Our Latest Thinking

  • Lawrence M. Green

    The Supreme Court says the Patent Act, which generally extends only to conduct occurring within the U.S., allows for enforcement of a U.S. patent against one specific overseas activity—the supplying of U.S.-made components to be assembled overseas in an infringing device. More...

  • Alexander J. Smolenski, Jr.

    A PTO memorandum, relying on a recent Federal Circuit decision, provides the life sciences industry with guidance on how to qualify method-of-treatment claims as patent-eligible subject matter. More...

  • Amy DeCloux, Ph.D., J.D.

    The recently signed Right to Try Act enables terminally ill patients to try experimental drugs that have completed Phase I testing but have not been approved by the FDA. It adds but little to existing “compassionate use” programs. More...

  • Steven A. Abreu

    A new study correlates companies’ pursuit of trademark registrations with the growth of their businesses. More...

  • Thomas C. Carey

    California’s new data privacy law requires many of the same protections that recently took effect in the EU. More...

  • Robert M. Asher

    PTAB Alert- The PTAB’s proposal to apply to IPRs the same claim construction standard used in federal litigation offers many benefits, but it may complicate validity challenges to indefinite claims. More...

Free Subscription

See more in Publications/News